Italian surveillance IT study modelled on cardiology and cancer care:
This article was originally published in Clinica
Executive Summary
Sassari regional hospital, in Sardinia, Italy, has launched a study into how best to apply IT to quality-assurance systems in cardiology and oncology. In collaboration with IT systems specialist TechSana, of the Orangee group, the six-month project will "explore the "potential of high-tech IT systems for optimising the use of risk-management indicators, surveillance and adverse-event reporting", in line with regulatory protocols covering these issues. The hospital's cardiology and oncology departments last year handled 250 coronary interventions and 550 new patients, respectively.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.